Only a handful of stem cell therapies are currently approved by the F.D.A., mainly for treating blood cancer and immune ...

Parkinson’s disease affects more than 10 million people worldwide. Discover its causes, symptoms, and the latest innovations ...

The FDA has approved Capsida Biotherapeutics' investigational new drug (IND) application for CAP-003 to treat Parkinson’s ...

Discover how Bayer and BlueRock are redefining biotech partnerships. From breakthrough Parkinson’s therapies to a unique “arm ...

An estimated 8,000 people in Singapore live with the disease. Read more at straitstimes.com. Read more at straitstimes.com.

XellSmart has completed multiple cases of iPSC-derived dopaminergic neural progenitor cell therapy for patients with ...

This first-in-human trial is testing a highly unconventional method: delivering fat-derived stem cells from the patient ...

Aspen Neuroscience, Inc. announced its participation in "Illuminating the Future," the International Society for Stem Cell ...

Despite a National Deep Brain Stimulation Service in operation since 2022, insufficient resources mean that many Irish ...

The sun found its way through the clouds as the first sod was cut for the advanced laboratory facility Cellerator, to be ...